ArticleCurrent microbiology2026
Isolation, Characterization and Liposome-Mediated Encapsulation of Potential Probiotic Lactic Acid Bacteria Isolated from Fermented Products.
Article in Current microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Lactic acid bacteria (LAB) are widely used in fermented foods and have been shown to support bone health, manage diabetes, and maintain microbiota balance. In this context, probiotics are key ingredients in functional food production. The aim of this study was to determine the probiotic potential of LAB strains isolated from homemade yogurt and kefir by functional characterizations and to load the most effective probiotic into liposomes to protect against gastrointestinal conditions in further functional studies. Among the Lactiplantibacillus sp. BC-10, Lactobacillus delbrueckii subsp. bulgaricus BC-16, Lacticaseibacillus sp. BC-8, L. helveticus BC-6 isolates provided within the scope of the study and whose functional properties were determined, L. delbrueckii subsp. bulgaricus BC-16 was evaluated as a safe and functionally effective probiotic with lower cytotoxic effect (only 14-21% inhibition at 50 µL/mL and 47 - 33% inhibition at 500 µL/mL), sensitivity to antibiotic species, high exopolysaccharide production (137.61 ± 25.85) and hydrophobic ability (90.97 ± 1.49) compared to other strains at high concentrations (50-500 µL/mL). L. delbrueckii subsp. bulgaricus BC-16 isolate was loaded into liposome structures and encapsulation efficiency was found to be approximately 86.8% and post-encapsulation process efficiency was 62.5%. At the end of in vitro gastrointestinal conditions, the number of free probiotic cells decreased from 8.25 log CFU/mL to 6.50 log CFU/mL, while the number of probiotic cells in the liposome decreased from 7.07 log CFU/mL to 6.90 log CFU/mL. These results indicate that liposome structures are beneficial for probiotic viability and stability.
Indexed as
Identifiers
41711918What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.